Detalles de la búsqueda
1.
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
BMC Cancer
; 23(1): 710, 2023 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516867
2.
COVID-19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS-CoV-2 Cluster During the First Wave of the COVID-19 Pandemic.
Oncologist
; 26(9): e1656-e1659, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028132
Resultados
1 -
2
de 2
1
Próxima >
>>